Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
PLETHICO PHARMA TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PLETHICO PHARMA Mar-14 |
TEVA PHARMA Dec-13 |
PLETHICO PHARMA/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 254 | 3,479 | - | |
Low | Rs | 31 | 3,022 | - | |
Sales per share (Unadj.) | Rs | 604.6 | 1,996.4 | - | |
Earnings per share (Unadj.) | Rs | 32.5 | 124.7 | - | |
Cash flow per share (Unadj.) | Rs | 51.3 | 286.1 | - | |
Dividends per share (Unadj.) | Rs | 0 | 109.18 | - | |
Avg Dividend yield | % | 0 | 3.4 | 0.0% | |
Book value per share (Unadj.) | Rs | 473.7 | 2,217.6 | - | |
Shares outstanding (eoy) | m | 34.07 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.2 | 1.6 | 14.5% | |
Avg P/E ratio | x | 4.4 | 26.1 | 16.8% | |
P/CF ratio (eoy) | x | 2.8 | 11.4 | 24.5% | |
Price / Book Value ratio | x | 0.3 | 1.5 | 20.5% | |
Dividend payout | % | 0 | 87.5 | 0.0% | |
Avg Mkt Cap | Rs m | 4,859 | 2,756,220 | 0.2% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 1,547 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,667.6 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,353.1 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 20,598 | 1,692,969 | 1.2% | |
Other income | Rs m | 419 | 0 | - | |
Total revenues | Rs m | 21,017 | 1,692,969 | 1.2% | |
Gross profit | Rs m | 2,938 | 463,620 | 0.6% | |
Depreciation | Rs m | 642 | 136,844 | 0.5% | |
Interest | Rs m | 1,747 | 33,253 | 5.3% | |
Profit before tax | Rs m | 968 | 293,523 | 0.3% | |
Minority Interest | Rs m | 0 | 1,333 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -192,682 | -0.0% | |
Tax | Rs m | -138 | -3,584 | 3.9% | |
Profit after tax | Rs m | 1,107 | 105,758 | 1.0% | |
Gross profit margin | % | 14.3 | 27.4 | 52.1% | |
Effective tax rate | % | -14.3 | -1.2 | 1,170.4% | |
Net profit margin | % | 5.4 | 6.2 | 86.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 18,877 | 1,143,425 | 1.7% | |
Current liabilities | Rs m | 11,896 | 997,163 | 1.2% | |
Net working cap to sales | % | 33.9 | 8.6 | 392.3% | |
Current ratio | x | 1.6 | 1.1 | 138.4% | |
Inventory Days | Days | 78 | 91 | 86.0% | |
Debtors Days | Days | 198 | 96 | 206.3% | |
Net fixed assets | Rs m | 14,269 | 552,961 | 2.6% | |
Share capital | Rs m | 341 | 4,167 | 8.2% | |
Net worth | Rs m | 16,139 | 1,880,567 | 0.9% | |
Long term debt | Rs m | 4,706 | 865,653 | 0.5% | |
Total assets | Rs m | 33,146 | 3,868,976 | 0.9% | |
Interest coverage | x | 1.6 | 9.8 | 15.8% | |
Debt to equity ratio | x | 0.3 | 0.5 | 63.3% | |
Sales to assets ratio | x | 0.6 | 0.4 | 142.0% | |
Return on assets | % | 8.6 | 3.6 | 239.6% | |
Return on equity | % | 6.9 | 5.6 | 122.0% | |
Return on capital | % | 13.0 | 4.9 | 264.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,437 | 269,772 | 0.9% | |
From Investments | Rs m | -6,265 | -95,591 | 6.6% | |
From Financial Activity | Rs m | 2,490 | -323,609 | -0.8% | |
Net Cashflow | Rs m | 24 | -149,429 | -0.0% |
Compare PLETHICO PHARMA With: ADCOCK INGRAM (S. Africa) MYLAN (US) ACTAVIS (US)
Compare PLETHICO PHARMA With: LINK PHARMA GANGA PHARMACEUTICALS BIOCON IND. SWIFT ORCHID PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.